(Q40248704)

18 September 2017

title

C-reactive protein promotes monocyte-platelet aggregation: an additional link to the inflammatory-thrombotic intricacy (English)

1 reference

18 September 2017

1 reference

Haim D Danenberg

1

1 reference

18 September 2017

Neelesh Kantak

2

1 reference

18 September 2017

Etty Grad

3

1 reference

18 September 2017

Rajesh V Swaminathan

4

1 reference

18 September 2017

Chaim Lotan

5

1 reference

18 September 2017

Elazer R Edelman

6

1 reference

18 September 2017

publication date

23 January 2007

1 reference

European Journal of Haematology

18 September 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

18 September 2017

volume

78

1 reference

18 September 2017

issue

3

1 reference

18 September 2017

page(s)

246-252

1 reference

Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00808.X

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00808.X

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00808.X

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00808.X

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00808.X

A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00808.X

C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00808.X

Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00808.X

Effects of C-reactive protein (CRP) on platelet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00808.X

Varied biologic functions of C-reactive protein: lessons learned from transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00808.X

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00808.X

Association of C-reactive protein with markers of prevalent atherosclerotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00808.X

Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00808.X

Human C-reactive protein: expression, structure, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00808.X

Effects of C-reactive protein on the release of von Willebrand factor, E-selectin, thrombomodulin and intercellular adhesion molecule-1 from human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00808.X

Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00808.X

C-reactive protein-induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00808.X

C-reactive protein does not relax vascular smooth muscle: effects mediated by sodium azide in commercially available preparations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00808.X

C-reactive protein-induced in vitro vasorelaxation is an artefact caused by the presence of sodium azide in commercial preparations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00808.X

Human C-reactive protein does not protect against acute lipopolysaccharide challenge in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00808.X

10.1111/J.1600-0609.2006.00808.X

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference